Skip to main content
Premium Trial:

Request an Annual Quote

Gene Signature IDs Fungal Infection in Mice

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A Duke University research team has pinned down gene expression signatures in mice that coincide with bloodstream infections caused by the fungal pathogen Candida albicans.

By comparing expression profiles in the blood of infected and uninfected mice, the researchers found a sensitive and specific signature in the infected mice that was not present in the healthy mice. After verifying this signature in another group of mice, the team explored the use of expression patterns for distinguishing between mice with Candida infections and bloodstream infections caused by the bacterial species Staphylococcus aureus — and even for tracking the stage of C. albicans infection.

"Our results show that this new gene-signature test works well to find candidemia in mice that had the infection versus mice without infection," co-lead author Aimee Zaas, a genetics, microbiology, and infectious disease researcher affiliated with Duke University School of Medicine and Duke's Institute for Genome Sciences and Policy, said in a statement. "We were very pleased to learn that we could further distinguish the fungal infection from a [Staphylococcus] infection, another bloodstream disease that shares the same set of symptoms."

Although they still need to do follow-up work in humans, those involved say the study, which appeared online yesterday in Science Translational Medicine, could pave the way for expression-based tests for diagnosing and treating Candida infections.

The team is reportedly in the process of collecting human samples with an eye toward developing a comparable gene expression-based blood test for detecting Candida infection in a clinical setting. At the moment, laboratory culture testing is used to distinguish between bacterial and fungal bloodstream infections — a process that can take two to three days and has limited sensitivity.

"This study provides the basis for development of a blood-gene expression test in humans to detect a life-threatening infection earlier than can be done using currently available methods," senior author Geoffrey Ginsburg, director of the Center for Genomic Medicine in Duke University's Institute for Genome Sciences and Policy, said in a statement.

"This work is also part of a portfolio of blood gene-expression-based tests we are developing to detect viral, bacterial and now fungal infections that will lead to more precise diagnosis and more appropriate therapies for infectious disease," Ginsburg added.

Candidemia and invasive candidiasis are bloodstream infections caused by fungi in the Candida genus. They are particularly problematic among immuno-compromised individuals in hospital or other healthcare settings, the researchers explained, and invasive candidiasis can not only prolong hospital visits but also increases mortality risk by more than ten percent.

For the current study, Zaas, Ginsburg, and co-workers focused on C. albicans, the most common cause of candidemia, looking for gene expression patterns associated with this type of infection in mice.

Using Affymetrix murine 430A 2.0 arrays, they compared the gene expression profiles in blood taken from 28 mice infected with C. albicans and a dozen healthy control mice, analyzing the full probe set and 2,093 probes corresponding to immune response genes separately.

Base on their evaluation of 20 sets of co-expressing genes, the team came up with a signature — involving 82 probes representing 67 genes involved in processes such as immune, defense, or stimulus response — that discerned cases from controls with 96 percent sensitivity and 100 percent specificity.

In the experiments that ensued, the researchers not only validated the signature in another 18 infected mice and five control mice, they also narrowed in on genes that are up- and down-regulated at early and late stages of invasive candidiasis infection.

Finally, by comparing expression patterns in 48 C. albicans-infected mice, 17 healthy control mice, and 17 mice infected with the bacterial species S. aureus, the team also illustrated that it's possible to use gene expression profiles to tell Candida infections apart from bloodstream infections caused by S. aureus.

"These findings provide compelling evidence that blood gene expression can accurately discriminate classes of infectious pathogens, specifically fungal infection from a common bacterial bloodstream infection," the researchers wrote, "and may potentially serve as a useful diagnostic for triaging treatment decisions for nosocomial infections, specifically candidemia."

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.